DC-SIGN ( CD 209 ) Mediates Dengue Virus Infection of Human Dendritic Cells
暂无分享,去创建一个
R. Steinman | D. Birx | M. Eller | K. Pattanapanyasat | T. Burgess | M. Marovich | S. Sarasombath | S. Schlesinger | C. Trumpfheller | A. Granelli‐Piperno | B. Tassaneetrithep | Wellington Sun | J. Finke
[1] B. Gicquel,et al. The Cell Surface Receptor DC-SIGN Discriminates betweenMycobacterium Species through Selective Recognition of the Mannose Caps on Lipoarabinomannan* , 2003, The Journal of Biological Chemistry.
[2] R. Steinman,et al. Cell type-dependent retention and transmission of HIV-1 by DC-SIGN. , 2003, International immunology.
[3] O. Schwartz,et al. DC-SIGN Is the Major Mycobacterium tuberculosis Receptor on Human Dendritic Cells , 2003, The Journal of experimental medicine.
[4] T. Geijtenbeek,et al. Mycobacteria Target DC-SIGN to Suppress Dendritic Cell Function , 2003, The Journal of experimental medicine.
[5] R. Steinman,et al. Preparation of clinical-grade recombinant canarypox-human immunodeficiency virus vaccine-loaded human dendritic cells. , 2002, The Journal of infectious diseases.
[6] R. Doms,et al. Quantitative Expression and Virus Transmission Analysis of DC-SIGN on Monocyte-Derived Dendritic Cells , 2002, Journal of Virology.
[7] B. Berkhout,et al. Differential Transmission of Human Immunodeficiency Virus Type 1 by Distinct Subsets of Effector Dendritic Cells , 2002, Journal of Virology.
[8] Á. Corbí,et al. C-Type Lectins DC-SIGN and L-SIGN Mediate Cellular Entry by Ebola Virus in cis and in trans , 2002, Journal of Virology.
[9] Philip K. Russell,et al. Hemorrhagic fever viruses as biological weapons: medical and public health management. , 2002, JAMA.
[10] D. Gubler. Epidemic dengue/dengue hemorrhagic fever as a public health, social and economic problem in the 21st century. , 2002, Trends in microbiology.
[11] M. Malim,et al. cis Expression of DC-SIGN Allows for More Efficient Entry of Human and Simian Immunodeficiency Viruses via CD4 and a Coreceptor , 2001, Journal of Virology.
[12] J. Mascola,et al. Human dendritic cells as targets of dengue virus infection. , 2001, The journal of investigative dermatology. Symposium proceedings.
[13] F. Ennis,et al. Human Dendritic Cells Are Activated by Dengue Virus Infection: Enhancement by Gamma Interferon and Implications for Disease Pathogenesis , 2001, Journal of Virology.
[14] M. Carrington,et al. A Dendritic Cell–Specific Intercellular Adhesion Molecule 3–Grabbing Nonintegrin (Dc-Sign)–Related Protein Is Highly Expressed on Human Liver Sinusoidal Endothelial Cells and Promotes HIV-1 Infection , 2001, The Journal of experimental medicine.
[15] R. Doms,et al. DC-SIGNR, a DC-SIGN homologue expressed in endothelial cells, binds to human and simian immunodeficiency viruses and activates infection in trans , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[16] D. Chang,et al. Infection of Human Dendritic Cells by Dengue Virus Causes Cell Maturation and Cytokine Production1 , 2001, The Journal of Immunology.
[17] Carl G. Figdor,et al. DC-SIGN–ICAM-2 interaction mediates dendritic cell trafficking , 2000, Nature Immunology.
[18] J. Mascola,et al. Human skin Langerhans cells are targets of dengue virus infection , 2000, Nature Medicine.
[19] C. Figdor,et al. Identification of DC-SIGN, a Novel Dendritic Cell–Specific ICAM-3 Receptor that Supports Primary Immune Responses , 2000, Cell.
[20] Douglas S Kwon,et al. DC-SIGN, a Dendritic Cell–Specific HIV-1-Binding Protein that Enhances trans-Infection of T Cells , 2000, Cell.
[21] C. King,et al. Analysis of the steps involved in Dengue virus entry into host cells. , 1999, Virology.
[22] C. King,et al. Bacterial Lipopolysaccharide Inhibits Dengue Virus Infection of Primary Human Monocytes/Macrophages by Blockade of Virus Entry via a CD14-Dependent Mechanism , 1999, Journal of Virology.
[23] G. Schuler,et al. Generation of large numbers of fully mature and stable dendritic cells from leukapheresis products for clinical application. , 1999, Journal of immunological methods.
[24] J. Esko,et al. Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate , 1997, Nature Medicine.
[25] D. Morens,et al. Dengue 1 virus binding to human hepatoma HepG2 and simian Vero cell surfaces differs. , 1996, The Journal of general virology.
[26] A. Nisalak,et al. Antibody-dependent enhancement of dengue virus growth in human monocytes as a risk factor for dengue hemorrhagic fever. , 1989, The American journal of tropical medicine and hygiene.
[27] A. Allison,et al. Dengue viruses and mononuclear phagocytes. II. Identity of blood and tissue leukocytes supporting in vitro infection , 1977, The Journal of experimental medicine.
[28] S. Halstead,et al. Antibody-enhanced dengue virus infection in primate leukocytes , 1977, Nature.
[29] W. Brandt,et al. Isolation of a temperature-sensitive dengue-2 virus under conditions suitable for vaccine development , 1976, Infection and immunity.
[30] A. Tokunaga,et al. A Summary of , 2011 .
[31] Bachti Alisjahbana,et al. Epidemiology of dengue and dengue hemorrhagic fever in a cohort of adults living in Bandung, West Java, Indonesia. , 2005, The American journal of tropical medicine and hygiene.
[32] W. Hendrickson,et al. DC-SIGN-mediated internalization of HIV is required for trans-enhancement of T cell infection. , 2002, Immunity.
[33] M. Colmenares. Dendritic-cell specific ICAM-3 grabbing nonintegrin (DC-SIGN, CD209), a C-type surface lectin in human dendritic cells, is a receptor for Leishmania amastigotes , 2002 .
[34] Dengue and dengue haemorrhagic fever. 1990-1994. , 1995, Releve epidemiologique hebdomadaire.
[35] A. Nisalak,et al. A prospective study of dengue infections in Bangkok. , 1988, The American journal of tropical medicine and hygiene.